Primary |
Drug Use For Unknown Indication |
43.1% |
Sinusitis |
14.8% |
Pneumonia |
11.1% |
Bronchitis |
8.6% |
Product Used For Unknown Indication |
4.6% |
Upper Respiratory Tract Infection |
2.5% |
Respiratory Tract Infection |
2.2% |
Infection |
2.1% |
Hypertension |
1.7% |
Chronic Obstructive Pulmonary Disease |
1.3% |
Lung Infection |
1.1% |
Urinary Tract Infection |
1.0% |
Unevaluable Event |
0.9% |
Nasopharyngitis |
0.9% |
Cough |
0.8% |
Ear Infection |
0.8% |
Acute Sinusitis |
0.7% |
Pyrexia |
0.7% |
Diabetes Mellitus |
0.6% |
Bronchopneumonia |
0.6% |
|
Rash |
12.2% |
Urticaria |
12.1% |
Vomiting |
9.5% |
Anaphylactic Reaction |
9.4% |
Tendonitis |
5.1% |
Hypersensitivity |
5.0% |
Nausea |
4.7% |
Tremor |
4.5% |
Tendon Rupture |
4.3% |
Pruritus |
4.2% |
Dizziness |
3.9% |
Anaphylactic Shock |
3.4% |
Paraesthesia |
3.2% |
Pain In Extremity |
2.8% |
Death |
2.7% |
Tendon Pain |
2.7% |
Dyspnoea |
2.6% |
Syncope |
2.6% |
Swelling Face |
2.6% |
Tachycardia |
2.3% |
|
Secondary |
Drug Use For Unknown Indication |
16.9% |
Product Used For Unknown Indication |
15.9% |
Pneumonia |
13.2% |
Sinusitis |
9.8% |
Bronchitis |
8.1% |
Chronic Obstructive Pulmonary Disease |
6.4% |
Hypertension |
5.3% |
Asthma |
5.1% |
Infection |
2.5% |
Pain |
2.4% |
Upper Respiratory Tract Infection |
1.9% |
Pyrexia |
1.9% |
Urinary Tract Infection |
1.9% |
Cough |
1.5% |
Hypersensitivity |
1.5% |
Psoas Abscess |
1.3% |
Osteoporosis |
1.2% |
Prophylaxis |
1.2% |
Respiratory Tract Infection |
1.1% |
Depression |
1.1% |
|
Vomiting |
17.7% |
Urticaria |
8.7% |
Tremor |
7.0% |
Tendon Rupture |
6.8% |
Drug Hypersensitivity |
6.2% |
Tendonitis |
5.5% |
Rotator Cuff Syndrome |
5.3% |
Weight Decreased |
4.9% |
Rash |
4.7% |
Pneumonia |
4.3% |
Pruritus |
4.1% |
Dyspnoea |
3.2% |
Pyrexia |
3.2% |
Paraesthesia |
3.0% |
Dizziness |
2.8% |
Tendon Pain |
2.8% |
Swelling |
2.6% |
Sinusitis |
2.4% |
Stevens-johnson Syndrome |
2.4% |
Syncope |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
31.8% |
Drug Use For Unknown Indication |
25.2% |
Diffuse Large B-cell Lymphoma |
4.5% |
Hypertension |
4.2% |
Pain |
3.8% |
Prophylaxis |
3.8% |
Multiple Myeloma |
2.7% |
Pneumonia |
2.6% |
Asthma |
2.5% |
Breast Cancer |
2.3% |
Osteoporosis |
2.0% |
Depression |
1.9% |
Nausea |
1.9% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Anxiety |
1.7% |
Metastases To Bone |
1.6% |
Infection |
1.6% |
Gastrooesophageal Reflux Disease |
1.6% |
Constipation |
1.3% |
Crohn's Disease |
1.3% |
|
Weight Decreased |
14.4% |
Vomiting |
12.5% |
Pneumonia |
11.8% |
Pulmonary Embolism |
7.7% |
Weight Increased |
5.2% |
Wound Infection Staphylococcal |
5.0% |
Wheezing |
4.5% |
Urinary Tract Infection |
3.8% |
White Blood Cell Count Decreased |
3.7% |
Death |
3.5% |
Pyrexia |
3.2% |
Dyspnoea |
3.1% |
Syncope |
3.0% |
Respiratory Failure |
2.8% |
Septic Shock |
2.8% |
Thrombocytopenia |
2.8% |
Sinusitis |
2.7% |
Vision Blurred |
2.6% |
Pain |
2.5% |
Wound Dehiscence |
2.5% |
|
Interacting |
Drug Use For Unknown Indication |
18.2% |
Chronic Sinusitis |
10.6% |
Cystitis |
6.8% |
Crohn's Disease |
6.1% |
Diabetes Mellitus |
6.1% |
Bronchitis |
5.3% |
Pneumonia |
5.3% |
Arrhythmia |
4.5% |
Disseminated Tuberculosis |
4.5% |
Nephrotic Syndrome |
4.5% |
Asthma |
3.0% |
Atrial Fibrillation |
3.0% |
Combined Immunodeficiency |
3.0% |
Cough |
3.0% |
Hypertension |
3.0% |
Pain |
3.0% |
Product Used For Unknown Indication |
3.0% |
Hyperlipidaemia |
2.3% |
Pulmonary Congestion |
2.3% |
Sinusitis |
2.3% |
|
Drug Interaction |
25.5% |
Tendon Rupture |
14.9% |
International Normalised Ratio Increased |
8.5% |
Hypoglycaemia |
4.3% |
Incision Site Abscess |
4.3% |
Malaise |
4.3% |
Somnolence |
4.3% |
Torsade De Pointes |
4.3% |
Tremor |
4.3% |
Urticaria |
4.3% |
Ageusia |
2.1% |
Aggression |
2.1% |
Electrocardiogram Qt Prolonged |
2.1% |
Gastrointestinal Haemorrhage |
2.1% |
Infection |
2.1% |
Mastitis |
2.1% |
Palpitations |
2.1% |
Panic Attack |
2.1% |
Post Procedural Infection |
2.1% |
Prothrombin Time Prolonged |
2.1% |
|